Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Copaxone
Copaxone
Teva catches break as warning letter looks to delay Momenta Copaxone generic
Fierce Pharma
Mon, 02/20/17 - 10:06 am
Teva Pharmaceutical
Momenta
Copaxone
MS
multiple sclerosis
generics
Top 25 rare disease brands, by sales
Medical Marketing and Media
Wed, 02/15/17 - 11:20 am
rare disease
Copaxone
Teva Pharmaceutical
Avonex
Biogen
Sensipar
Soliris
Alexion
Xyrem
Jazz Pharmaceuticals
If copies of Teva's Copaxone hit, oral MS rivals could be the real threat
Fierce Pharma
Wed, 02/15/17 - 09:41 am
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
generics
Tecfidera
Biogen
Gilenya
Novartis
Aubagio
Sanofi
Are Teva Pharmaceutical's Best Days Behind It?
Motley Fool
Wed, 02/1/17 - 05:36 pm
Teva Pharmaceutical
Copaxone
generics
patents
MS
multiple sclerosis
Teva shares fall as court invalidates patent infringement claims
Marketwatch
Mon, 01/30/17 - 10:51 pm
Teva Pharmaceutical
patents
Copaxone
Mylan Labs
multiple sclerosis
MS
Third U.S. patent on Teva's MS drug Copaxone invalidated
Reuters
Fri, 09/2/16 - 11:29 am
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
patents
Generics creep in as Teva loses two Copaxone patents
BioPharma Dive
Fri, 08/26/16 - 09:55 am
Teva Pharmaceutical
Copaxone
patents
MS
multiple sclerosis
generics
Glatopa
Novartis
Sandoz
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
Motley Fool
Wed, 08/24/16 - 05:40 pm
Momenta Pharmaceuticals
Teva Pharmaceutical
Copaxone
patents
Mylan Labs
multiple sclerosis
MS
Payers keep squeezing MS drugmakers--and they may just take their tactics elsewhere
Fierce Pharma
Wed, 06/22/16 - 07:08 pm
MS
multiple sclerosis
payers
Sanofi
Aubagio
Teva Pharmaceutical
Copaxone
Biogen
Tecfidera
Avonex
How are Teva and Novartis fending off copycats? By taking discounts straight to payers, analyst says
Fierce Pharma
Sat, 04/2/16 - 02:04 pm
Teva Pharmaceutical
Novartis
Gleevec
Copaxone
generics
Why is Novartis' Copaxone copy lagging? It's all about coverage, analyst explains
Fierce Pharma
Fri, 09/11/15 - 05:53 pm
Novartis
Copaxone
MS
multiple sclerosis
biosimilars
Teva
Glatopa
Analysts at Merrill Lynch believe Mylan’s patent challenge will not have a negative impact on Teva
Bidness, ETC
Fri, 08/28/15 - 08:02 am
Mylan Labs
Teva Pharmaceutical
patents
generics
Copaxone
MS
multiple sclerosis
U.S. patent office puts new Copaxone's IP shield under the lens
Fierce Pharma
Wed, 08/26/15 - 08:28 pm
patents
intellectual property
Copaxone
MS
multiple sclerosis
Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Yahoo
Mon, 08/3/15 - 09:09 am
Pfizer
Synthon Pharmaceuticals
MS
multiple sclerosis
Copaxone
generics
Teva's MS drug Copaxone has strong second-quarter sales
Yahoo/Reuters
Thu, 07/30/15 - 10:31 am
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
earnings
Novartis off to scorching start with Copaxone generic Glatopa
Fierce Pharma Marketing
Mon, 07/13/15 - 11:11 am
Novartis
Copaxone
generics
Glatopa
MS
multiple scleroiss
Momenta
Sandoz
It's Teva vs. Momenta/Sandoz for Copaxone patients, with Mylan's version MIA
Fierce Pharma Marketing
Mon, 06/22/15 - 10:52 am
Teva Pharmaceutical
Momenta
Sandoz
generics
Novartis
Copaxone
MS
multiple sclerosis
U.S. court nixes Teva's Copaxone patent--again
Fierce Pharma
Thu, 06/18/15 - 04:00 pm
Copaxone
patents
Teva Pharmaceuticals
generics
Momenta
Novartis
Sandoz
Small group of branded drugs like Nexium, Copaxone make up huge part of Medicare spend
Fierce Pharma
Sat, 05/2/15 - 01:10 pm
Nexium
Copaxone
Medicare
generics
Is Teva considering a $34B Mylan buyout to offset Copaxone losses?
BioPharma Dive
Mon, 04/20/15 - 11:59 am
Teva Pharmaceutical
Mylan
M&A
Copaxone
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »